TRDA · Insider trading · 13F holders · Congress trades
Entrada Therapeutics, Inc. (TRDA)
Who is buying and selling TRDA: company insiders on SEC Form 4, hedge funds and superinvestors on Form 13F, and members of Congress under the STOCK Act. Every figure links to the filing or page it comes from.
- 13F filers holding
- 8
- Insider buys, 90 days
- $0
- Insider sales, 90 days
- $10.3M
- Congress trades, 12 months
- 0
TRDA at a glance
- Between Aug 1, 2026 and Oct 29, 2026, 4 TRDA insiders filed 12 sales worth $10.3M on SEC Form 4, and no open-market purchases.
- 8 13F filers hold TRDA among their 50 largest positions, worth $104.3M combined, including Julian and Felix Baker. The biggest bets by portfolio weight are 5AM Venture Management, LLC (10.4%), Merck & Co., Inc. (2.4%) and Mpm Bioimpact LLC (0.6%). In their latest 13Fs, 2 managers opened a new position and 0 added to one.
- No member of Congress has disclosed a trade in TRDA.
- TRDA last closed at $4.40 on Oct 29, 2026.
TRDA insider trading
Between Aug 1, 2026 and Oct 29, 2026, 4 TRDA insiders filed 12 sales worth $10.3M on SEC Form 4, and no open-market purchases.
| Filed | Insider | Role | Trade | Shares | Price | Value | Form 4 |
|---|---|---|---|---|---|---|---|
| Sep 9, 2026 | Mpm Bioventures 2018, L.P. | 10% Owner | Sale | 259,837 | $7.33 | $1.9M | SEC |
| Sep 9, 2026 | MPM BioVentures 2014, L.P. | 10% Owner | Sale | 259,837 | $7.33 | $1.9M | SEC |
| Sep 3, 2026 | Mpm Bioventures 2018, L.P. | 10% Owner | Sale | 86,482 | $7.14 | $617K | SEC |
| Sep 3, 2026 | MPM BioVentures 2014, L.P. | 10% Owner | Sale | 86,482 | $7.14 | $617K | SEC |
| Aug 31, 2026 | Mpm Bioventures 2018, L.P. | 10% Owner | Sale | 86,914 | $7.08 | $616K | SEC |
| Aug 31, 2026 | MPM BioVentures 2014, L.P. | 10% Owner | Sale | 86,914 | $7.08 | $616K | SEC |
| Aug 26, 2026 | MPM BioVentures 2014, L.P. | 10% Owner | Sale | 62,714 | $7.36 | $462K | SEC |
| Aug 26, 2026 | Mpm Bioventures 2018, L.P. | 10% Owner | Sale | 62,714 | $7.36 | $462K | SEC |
| Aug 10, 2026 | Parmar Kush | Director | Sale | 155,255 | $6.95 | $1.1M | SEC |
| Aug 10, 2026 | 5AM Ventures V, L.P. | 10% Owner | Sale | 62,811 | $6.88 | $432K | SEC |
| Aug 3, 2026 | 5AM Ventures V, L.P. | 10% Owner | Sale | 116,474 | $6.93 | $807K | SEC |
| Aug 3, 2026 | Parmar Kush | Director, 10% Owner | Sale | 116,474 | $6.93 | $807K | SEC |
Who owns TRDA? Hedge funds and superinvestors
8 13F filers hold TRDA among their 50 largest positions, worth $104.3M combined, including Julian and Felix Baker. The biggest bets by portfolio weight are 5AM Venture Management, LLC (10.4%), Merck & Co., Inc. (2.4%) and Mpm Bioimpact LLC (0.6%). In their latest 13Fs, 2 managers opened a new position and 0 added to one.
Superinvestors holding TRDA: Julian and Felix Baker 0.2%
| Manager | % of portfolio | Value | Shares | Last quarter | 13F |
|---|---|---|---|---|---|
| Julian and Felix BakerHedge fund | 0.2% | $37.3M | 5,072,730 | +0.0% shares | Q2 2026 |
| 5AM Venture Management, LLCVenture capital | 10.4% | $29.9M | 4,056,379 | +0.0% shares | Q2 2026 |
| Merck & Co., Inc.Corporation | 2.4% | $12.8M | 1,739,768 | New | Q2 2026 |
| Mpm Bioimpact LLCHedge fund | 0.6% | $9.2M | 1,253,053 | New | Q2 2026 |
| TCG Crossover Management, LLCHedge fund | 0.2% | $7.8M | 1,060,230 | -53.7% shares | Q2 2026 |
| StepStone Group LPHedge fund | 0.3% | $5.6M | 761,277 | +0.0% shares | Q2 2026 |
| Lynx1 Capital Management LPHedge fund | 0.2% | $1.3M | 178,606 | -15.6% shares | Q2 2026 |
| Nan Fung Group Holdings LtdInvestment manager | 0.3% | $361K | 49,082 | +0.0% shares | Q2 2026 |
Each manager counts with its latest 13F (Q2 2026: 8). Screen TRDA in the grand portfolio →
TRDA stock trades by members of Congress
No member of Congress has disclosed a trade in TRDA.
TRDA questions and answers
Are insiders buying TRDA stock?
Between Aug 1, 2026 and Oct 29, 2026, 4 TRDA insiders filed 12 sales worth $10.3M on SEC Form 4, and no open-market purchases.
Which hedge funds own TRDA?
8 13F filers hold TRDA among their 50 largest positions, worth $104.3M combined, including Julian and Felix Baker. The biggest bets by portfolio weight are 5AM Venture Management, LLC (10.4%), Merck & Co., Inc. (2.4%) and Mpm Bioimpact LLC (0.6%). In their latest 13Fs, 2 managers opened a new position and 0 added to one.
Has Congress traded TRDA?
No member of Congress has disclosed a trade in TRDA.
Who is the largest holder of TRDA?
Among 13F filers, Julian and Felix Baker reports the largest TRDA position, $37.3M (5,072,730 shares) in its Q2 2026 13F. The biggest bet by portfolio weight is 5AM Venture Management, LLC's: 10.4% of its portfolio.
Cite or share this
Free to use with a link back. The data updates every filing day.